Alongside, preclinical studies can help understand the role of MET inhibitors in models of breast cancer and analyze the role of MET in responding to endocrine treatment to pave the way for clinical trials to explore the usefulness of combinational treatment approaches of MET inhibitors and hormonal therapies. The gene discussed is MET; the disease is breast cancer.